Back to School: How biopharma can reboot drug development. Access exclusive analysis here

OSI raises $175M in note deal

OSI (NASDAQ:OSIP) raised $175 million in a bumped-up placement of convertible senior subordinated

Read the full 135 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE